Burning Rock Biotech Limited
BNR
$16.76
-$0.07-0.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.71% | 2.33% | 4.56% | 4.56% | 4.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.71% | 2.33% | 4.56% | 4.56% | 4.47% |
| Cost of Revenue | -23.07% | -10.92% | -11.80% | -11.80% | -14.51% |
| Gross Profit | 11.85% | 7.64% | 12.19% | 12.19% | 14.90% |
| SG&A Expenses | -8.53% | -9.55% | -51.04% | -51.04% | -50.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.77% | -11.63% | -41.80% | -41.80% | -39.64% |
| Operating Income | 73.90% | 58.19% | 88.09% | 88.09% | 71.76% |
| Income Before Tax | 80.62% | 53.44% | 89.20% | 89.20% | 52.67% |
| Income Tax Expenses | -83.27% | 5.34% | 22.71% | 22.71% | 398.11% |
| Earnings from Continuing Operations | 80.79% | 53.11% | 89.04% | 89.04% | 49.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 80.79% | 53.11% | 89.04% | 89.04% | 49.70% |
| EBIT | 73.90% | 58.19% | 88.09% | 88.09% | 71.76% |
| EBITDA | 80.18% | 42.63% | 97.52% | 97.52% | 74.46% |
| EPS Basic | 81.05% | 55.08% | 89.55% | 89.55% | 50.17% |
| Normalized Basic EPS | 64.44% | 55.39% | 89.71% | 89.71% | 74.79% |
| EPS Diluted | 81.05% | 55.08% | 89.55% | 89.55% | 50.17% |
| Normalized Diluted EPS | 64.44% | 55.39% | 89.71% | 89.71% | 74.79% |
| Average Basic Shares Outstanding | 1.36% | 4.37% | 4.95% | 4.95% | 0.94% |
| Average Diluted Shares Outstanding | 1.35% | 4.38% | 4.94% | 4.94% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |